Bio-Rad Laboratories | BIO - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.27B 138M 2026-03
Agilent USD 476M 48M 2025-12
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Bio Techne USD 109.34M 4.35M 2026-03
Bio-Rad Laboratories USD 221M 14.2M 2025-12
Bruker USD 242.1M 5.1M 2026-03
Charles River Laboratories USD 159.42M 36.71M 2026-03
Danaher USD 1.86B 166M 2026-03
General Electric Aerospace USD 1.08B 496M 2026-03
Illumina USD 272M 11M 2026-03
IQVIA Holdings USD 502M 34M 2026-03
Laboratory Of America USD 551M 12.4M 2026-03
Merck USD 2.67B 180M 2026-03
Mettler Toledo International USD 258.33M 1.5M 2026-03
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Repligen USD 76.54M 2.17M 2026-03
Revvity USD 253.88M 2.15M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
Siemens EUR 3.56B 45M 2026-03
Standard Biotools USD 21.55M 5.05M 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Tosoh JPY 44.48B 2.96B 2026-03
Waters USD 394M 153.99M 2026-03